Professional Documents
Culture Documents
PRELIMINARY NOTES
Glossary
All definitions for Alternative Performance Measures (APM’s) are available in the Glossary of the
Annual Report and on the investor portal (www.barco.com/en/about-barco/investors)
3
A TRUSTED PARTNER
+80 180
EBITDA
153,0
140
120
70% 100
80
of Fortune 500 companies
58,5
53,6
60
40
20
2019
2020
2021
3.100 0
14.10% 7.00% 7.30%
4
PRESENT AROUND THE WORLD
38% EMEA
25% Asia-Pacific
5
BARCO’S VISION
We envision
6
ENABLING OUTCOMES
PROVIDING EXPERT KNOWLEDGE & SUPPORT
7
IN HEALTHY MARKETS WITH A CLEAR PURPOSE
39% entertainment
29% enterprise
33% healthcare
15
INNOVATION
16
WHERE SUSTAINABILITY PLAYS AN ESSENTIAL ROLE
guided by the UN Sustainable Development Goals
19
RESULTING IN SUSTAINABLE CREDITS
Low risk
20
PLANET | SHARPENING OUR AMBITIONS
We lower our
environmental
footprint and
2020
2023 -35%
-20% 70%
25% that of our
customers
Target
22
REPRESENTED BY A DIVERSE & INTERNATIONAL TEAM
27%
employees
16%
senior management
representation 9% < 30year
by nationality
63% 30y-50y
50%
28% > 50y
board directors
44 nationalities
employed in our
company
23
RETROSPECT 2021
25
RESULTS 2021 | EXECUTIVE SUMMARY
Business recovery translates into solid order intake and all-time-high orderbook
27 Profitability impacted by supply chain restrictions
DYNAMIC THROUGH THE YEAR | QUARTERLY RESULTS
Encouraging quarterly results
Orders Sales
PLANET
Solid increase of ECO-labelled revenues fueled by
FY19 FY20 FY21 Change more and more ECO-labelled product releases
% Revenues from ECO Footprint reduction temporarily stalled (-33%
- 26% 31% +5 ppts
labelled products reduction vs baseline 2015) due to mix:
CO2 emissions reduction
-20% -34% -33% -1 ppts o logistics emissions (supply chain constraints)
vs 2015
o mobility (travel & fuel emissions reflecting
lockdowns & travel restrictions)
PEOPLE
Employee net promotor starts with 38.5 score,
FY21 breeding into the “great” category
Employee NPS (eNPS) 38.5
COMMUNITIES
FY20 FY21 Change Customer NPS at par with last year & solidifying
Customer NPS 47 47 0 outcome (responses ) and actionable
33
LOOKING BACK & FORWARD
2017 2018 2019 2020 2021 2022 2023 2017 2018 2019 2020 2021 2022 2023 2018 2019 2020 2021 2022 2023
Hospital budget allocations back to Back to office to gradually kick Cinema to further expand with
normal in for real ; hybrid new builds (MEA, China, Latam)
collaboration as norm
Mammo radiology back to normal Renewal wave (EMEA, US) to only
Continued investments in large gradually kick in as of 2H22
Upscaling elective surgery & OR videowall
digitization to expand Events to reignite as of mid ‘22
Remote learning investments
to accelerate
Integrate sustainability
35
OUTLOOK 1H 2022
The following statements are forward looking, and actual results may differ materially
For the first half of 2022, and assuming no further deterioration of the supply chain
constraints, management expects sales to increase approximately 20% compared to
1H21. EBITDA margin for the first half is expected to be higher than the full year 2021
EBITDA margin, reflecting gradually improving gross profit margin and operating
leverage on higher sales.
The company is not providing a full year outlook for 2022 as visibility for the year is
currently limited and business conditions may change substantially over the year.
36
OPTIONAL DIVIDEND
“The Board of Directors will propose to the General Assembly to increase the dividend from
0.378 euro a year ago to 0.40 euro per share to be paid out in 2022, a 5% increase.
In line with last year, Barco’s shareholders will be offered the choice between payment in
cash or dividend in shares, enabling Barco’s shareholders to reinvest in the company.”
Modalities
◦ Issue price per new share: €19.60
◦ Contribution ratio: 70 dividend rights for the financial year 2021 (the "Dividend right")
amounting to the net dividend of € 0.28
Agenda
Ex-date 9/05/2022
Record date: 10/05/2022
Option period: 11/05 - 3/06
Payment date: 9/06/2022
37
REDESIGN TO A PERFORMANT MATRIX ORGANIZATION
TOWARDS A CUSTOMER-DRIVEN ORGANIZATION
Simplified…
A more agile and focused organization with clear end-
to-end accountability
Regrouping sales, marketing, product management,
R&D in business units
Shorter reporting lines, faster decision making
Enhanced market and customer responsiveness
ENTERTAINMENT
HEALTHCARE
m€ 1Q22 1Q21 Change
Sales strong fueled by mainly the Surgical and Modality segment
Orders 86.4 93.9 -8%
While yoy orders down vs peak in 1Q21, orderbook up
Sales 77.7 63.5 +22%
40
DIVISIONAL UPDATE
41
Entertainment
division
(in millions of euro) 2021 Δ 2020
ENTERTAINMENT Orders 386.6 43.9%
Markets unlock but with limitations, back-to-normal investments Sales 309.7 6.3%
Orders Sales
4Q21 orders and sales passing pre-covid 1Q20 levels; building
orderbook, on strength of continued uptakes in both segments
Cinema industry rebounds for real in 2H21 with re- Events: still slow with prolonged lockdown measures ww
openings and strong movie slate
ProAV: strong and global resumption of activity in digital
China expansion continues and remains strong immersive art and fixed installs; China back to normal;
commercial focus and value prop yields results
Varied growth rates in rest of the world in 2021
◦ New build deployment in selected regions
Simulation expanding value prop and building orderbook
◦ Major replacement programs pushed out with reference customers but slow conversion to sales
◦ Retrofit programs start to kick in; premium experience gains
traction (IMAX, CGS)
43
INTRODUCTION, QUICK FACTS AND RETROSPECTIVE
45
KEY FIGURES
46
Enterprise
division
2021 Δ 2020
ENTERPRISE
(in millions of euro)
Orders Sales
Gradual resumption of order growth with a strong 2nd half order
intake in both business segments
Growing adoption for wireless conferencing & growth Overall markets resilient, delays in corporate projects due to site
correlates with back-to-office dynamics access and component shortage but with healthy rebound in 4Q21
ClickShare recovery is led by strong growth in EMEA, slower Significant pick-up in Americas, reflecting share gain; reboot
growth in the Americas (US) and Asia lagging (lockdowns) needed in China
ClickShare now in nearly 1 million meeting rooms Expanded value proposition (triple play and software) shows
value-add & strengthens competitive position; service propositions
ClickShare conference @ 45% of ClickShare sales (4Q21 -
driving growth
volume)
Profitability still lagging
54
INTRODUCTION, QUICK FACTS AND RETROSPECTIVE
56
KEY FIGURES
57
Healthcare
division
(in millions of euro) 2021 Δ 2020
HEALTHCARE Orders 329.8 25.8%
Rebound in hospital investment plans; conversion to sales Sales 261.5 -0.1%
hampered by components scarcity EBITDA 22.4 (12.6)
% Sales Change (ppts) 8.6% -4.8
Orders Sales
Orders strong (+20%) on intensified long-term demand for Digital & integrated operating rooms market expanding
Diagnostics solutions (led by NA) Surgical broadening the partner base and growing business with
Sales slightly down deployments impacted by prolonged strategic partners, resulting in very solid order intake
effects of the pandemic Modest sales growth as hospitals are still somewhat hampered to
move towards normalized operations and investments
Renewing and expanding portfolio including new
pathology display, collaboration enabled displays and remote Expanding share of wallet with launch of NexxisLive platform
fleet optimization solutions
66
INTRODUCTION, QUICK FACTS AND RETROSPECTIVE
68
KEY FIGURES
69
CONCLUSION
73
CONCLUSION
THANK YOU
76
THANK YOU
77
Discover more?
www.barco.com
| youtube.com/BarcoTV
| linkedin.com/company/Barco
| twitter.com/Barco
| facebook.com/Barco
79